These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22695717)

  • 1. Cardiotonic steroids stabilize regulator of G protein signaling 2 protein levels.
    Sjögren B; Parra S; Heath LJ; Atkins KB; Xie ZJ; Neubig RR
    Mol Pharmacol; 2012 Sep; 82(3):500-9. PubMed ID: 22695717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin-Mediated Upregulation of RGS2 Protein Protects against Cardiac Injury.
    Sjögren B; Parra S; Atkins KB; Karaj B; Neubig RR
    J Pharmacol Exp Ther; 2016 May; 357(2):311-9. PubMed ID: 26941169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats.
    Wu Y; Nakagawa S; Takahashi H; Kawabata Y; Suzuki E; Uehara Y
    Hypertens Res; 2016 May; 39(5):295-301. PubMed ID: 26763849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of protein kinase C activation as a novel mechanism for RGS2 protein upregulation through phenotypic screening of natural product extracts.
    Raveh A; Schultz PJ; Aschermann L; Carpenter C; Tamayo-Castillo G; Cao S; Clardy J; Neubig RR; Sherman DH; Sjögren B
    Mol Pharmacol; 2014 Oct; 86(4):406-16. PubMed ID: 25086086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depth of the Steroid Core Location Determines the Mode of Na,K-ATPase Inhibition by Cardiotonic Steroids.
    Tverskoi AM; Poluektov YM; Klimanova EA; Mitkevich VA; Makarov AA; Orlov SN; Petrushanko IY; Lopina OD
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a cAMP-response element in the regulator of G-protein signaling-2 (RGS2) promoter as a key cis-regulatory element for RGS2 transcriptional regulation by angiotensin II in cultured vascular smooth muscles.
    Xie Z; Liu D; Liu S; Calderon L; Zhao G; Turk J; Guo Z
    J Biol Chem; 2011 Dec; 286(52):44646-58. PubMed ID: 22057271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of c-SRC underlies the differential effects of ouabain and digoxin on Ca(2+) signaling in arterial smooth muscle cells.
    Zulian A; Linde CI; Pulina MV; Baryshnikov SG; Papparella I; Hamlyn JM; Golovina VA
    Am J Physiol Cell Physiol; 2013 Feb; 304(4):C324-33. PubMed ID: 23195071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1
    Marck PV; Pessoa MT; Xu Y; Kutz LC; Collins DM; Yan Y; King C; Wang X; Duan Q; Cai L; Xie JX; Lingrel JB; Xie Z; Tian J; Pierre SV
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGS2 is a primary terminator of β₂-adrenergic receptor-mediated G(i) signaling.
    Chakir K; Zhu W; Tsang S; Woo AY; Yang D; Wang X; Zeng X; Rhee MH; Mende U; Koitabashi N; Takimoto E; Blumer KJ; Lakatta EG; Kass DA; Xiao RP
    J Mol Cell Cardiol; 2011 Jun; 50(6):1000-7. PubMed ID: 21291891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
    Schoner W; Scheiner-Bobis G
    Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotonic steroids as potential Na
    Patel CN; Kumar SP; Modi KM; Soni MN; Modi NR; Pandya HA
    J Recept Signal Transduct Res; 2019 Jun; 39(3):226-234. PubMed ID: 31509043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
    Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
    Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Terminal Targeting of Regulator of G Protein Signaling Protein 2 for F-Box Only Protein 44-Mediated Proteasomal Degradation.
    McNabb HJ; Gonzalez S; Muli CS; Sjögren B
    Mol Pharmacol; 2020 Dec; 98(6):677-685. PubMed ID: 33008920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of cardiotonic steroids to Na
    Kanai R; Cornelius F; Ogawa H; Motoyama K; Vilsen B; Toyoshima C
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33318128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine-1-phosphate regulates RGS2 and RGS16 mRNA expression in vascular smooth muscle cells.
    Hendriks-Balk MC; Hajji N; van Loenen PB; Michel MC; Peters SL; Alewijnse AE
    Eur J Pharmacol; 2009 Mar; 606(1-3):25-31. PubMed ID: 19374869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced proliferation and altered calcium handling in RGS2-deficient vascular smooth muscle cells.
    Momen A; Afroze T; Sadi AM; Khoshbin A; Zhang H; Choi J; Gu S; Zaidi SH; Heximer SP; Husain M
    J Recept Signal Transduct Res; 2014 Dec; 34(6):476-83. PubMed ID: 24846582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells.
    Grant SL; Lassègue B; Griendling KK; Ushio-Fukai M; Lyons PR; Alexander RW
    Mol Pharmacol; 2000 Mar; 57(3):460-7. PubMed ID: 10692485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells.
    Bodenstein J; Sunahara RK; Neubig RR
    Mol Pharmacol; 2007 Apr; 71(4):1040-50. PubMed ID: 17220356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss-of-Function Mutations in Human Regulator of G Protein Signaling RGS2 Differentially Regulate Pharmacological Reactivity of Resistance Vasculature.
    Phan HTN; Jackson WF; Shaw VS; Watts SW; Neubig RR
    Mol Pharmacol; 2019 Dec; 96(6):826-834. PubMed ID: 31645376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
    Schoner W; Scheiner-Bobis G
    Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.